Sjögren's disease trials in China

In China 30 Also abroad 80

30 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Where
Beijing, Chengdu, Jiujiang, Nanjing, Ningbo, Shenzhen, Taiyuan, Wenzhou
Age
18 years and over
People
570 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07621809 · EU 2025-522271-29-00
Phase 2Taking people
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Where
Beijing, Hefei, Nanjing, Taiyuan
Age
18 years to 100 years
People
344 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07737743 · EU 2025-524513-92-00
No phaseNot yet taking people in China
MYTP01 for Immune-Mediated Diseases
Where
Hangzhou
Age
18 years to 65 years
People
160
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT07901764
Phase 1Taking people
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
Where
Beijing, Bengbu, Changsha, Guangzhou, Hangzhou, Hefei, Jinan, Linyi, Luoyang, Nanjing, Shanghai, Suzhou, Taiyuan, Wuhan, Xiamen, Xi'an, Zhengzhou
Age
18 years and over
People
149
Run by
Antengene Biologics Limited
See details and how to joinNCT07732309
No phaseTaking people
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
Where
Shanghai
Age
18 years to 65 years
People
6
Run by
China Immunotech (Beijing) Biotechnology Co., Ltd.
See details and how to joinNCT06379646
Phase 1Taking people
A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
Where
Shanghai
Age
18 years to 65 years
People
12
Run by
Therorna
See details and how to joinNCT07413341
No phaseTaking people
Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease
Where
Beijing
Age
18 years to 70 years
People
60
Run by
Peking University People's Hospital
See details and how to joinNCT07843381
Early phase 1Taking people
Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases
Where
Beijing
Age
18 years to 80 years
People
10
Run by
Peking University Third Hospital
See details and how to joinNCT07301164
Phase 2Not yet taking people in China
A Study of IBI355 in Participants With Moderate-to-Severe Sjögren's Disease
Where
Hefei
Age
18 years to 75 years
People
198
Run by
Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07836660
Phase 1/2Taking people
Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Where
Beijing
Age
18 years to 80 years
People
9
Run by
Peking University Third Hospital
See details and how to joinNCT06828042
Early phase 1Not yet taking people in China
CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases
Where
Shanghai
Age
18 years to 70 years
People
30
Run by
Nanjing Bioheng Biotech Co., Ltd.
See details and how to joinNCT07596680
Early phase 1Taking people
MTS109 in Patients With Refractory Autoimmune Diseases
Where
Shanghai
Age
18 years to 65 years
People
15
Run by
Shanghai Changzheng Hospital
See details and how to joinNCT07526350
Phase 1Not yet taking people in China
CM336 for Active Sjogren's Syndrome Study
Where
Beijing
Age
18 years to 75 years
People
30
Run by
Keymed Biosciences Co.Ltd
See details and how to joinNCT07642843
Early phase 1Taking people
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
Where
Bengbu
Age
18 years to 70 years
People
20
Run by
Nanjing Bioheng Biotech Co., Ltd.
See details and how to joinNCT06548607
Phase 1Taking people
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Where
Bengbu
Age
18 years to 65 years
People
18
Run by
China Immunotech (Beijing) Biotechnology Co., Ltd.
See details and how to joinNCT07236762
Phase 1/2Taking people
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
Where
Beijing
Age
6 years to 65 years
People
45
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06947473
Phase 1Taking people
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
Where
Xuzhou
Age
18 years to 65 years
People
18
Run by
China Immunotech (Beijing) Biotechnology Co., Ltd.
See details and how to joinNCT07236801
Phase 1Not yet taking people in China
YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases
Where
Shanghai
Age
5 years to 18 years
People
12
Run by
Children's Hospital of Fudan University
See details and how to joinNCT07439029
No phaseNot yet taking people in China
A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
Where
Tianjin
Age
18 years to 65 years
People
24
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07212322
Phase 1/2Taking people
Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
Where
Beijing
Age
18 years to 80 years
People
60
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07062523
No phaseNot yet taking people in China
A Study of Yiqi Yangyin Formula in the Treatment of Primary Sjogren's Syndrome
Where
Beijing
Age
18 years to 75 years
People
105
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07145060
Phase 1/2Taking people
Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome
Where
Shanghai
Age
18 years to 70 years
People
6
Run by
Bangdong Gong
See details and how to joinNCT06967038
Phase 2Taking people
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Where
Beijing
Age
18 years to 65 years
People
50
Run by
Peking University People's Hospital
See details and how to joinNCT06794008
No phaseEnrolling by invitation
Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases
Where
Shanghai
Age
18 years to 65 years
People
15
Run by
Bioray Laboratories
See details and how to joinNCT05859997
Phase 1/2Taking people
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Where
Beijing
Age
21 years to 90 years
People
60
Run by
Essen Biotech
See details and how to joinNCT06428188